Zobrazeno 1 - 10
of 60
pro vyhledávání: '"B. Mascret"'
Autor:
B. Mascret, Y. Carcassonne, J. Camerlo, G. Sebahoun, G. Novakovitch, H. Perrimond, D. Maraninchi, G. Lepeu, J.A. Gastaut, F. Rossi
Publikováno v:
Revue Francaise de Transfusion et Immuno-hématologie. 28:477-488
Autor:
G. Sebahoun, C. Simon-Lejeune, J. R. Delpero, N. Mathieu-Tubiana, Blanc Ap, Dominique Maraninchi, Jean-Albert Gastaut, Yves Carcassonne, Y. P. Letreut, G. Guerinel, B. Mascret, A. Caamano
Publikováno v:
Cancer. 59:340-345
Between January 1, 1980, and July 31, 1985, 168 patients were treated at our institution for chronic lymphocytic leukemia (CLL). Splenectomy was performed on 32 (23 men and 9 women). The mean age of these surgical patients was 59.4 years (range, 43-7
Autor:
J. Camerlo, B. Mascret, C. Lejeune, D. Maraninchi, D. Sainty, J.A. Gastaut, G. Sebahoun, Carcassone Y, N. Tubiana, N. Horschowski, G. Novakovitch
Publikováno v:
European Journal of Cancer and Clinical Oncology. 22:461-471
Twenty-eight patients with malignant lymphoma were treated with high dose chemo or chemoradiotherapy and allogeneic or autologous bone marrow transplantation. They can be divided in two groups: Group 1: (19 pts) consisted in patients in relapse or in
Autor:
D, Sainty, N, Horschowski, C, Fossat, N, Tubiana, F, Le Caer, G, Sebahoun, B, Mascret, C, Lejeune, Y, Carcassonne
Publikováno v:
Annales de medecine interne. 138(2)
The role played by T lymphocytes in myelopoiesis has been established in in vitro studies. Dysregulation of the lymphoid system results in quantitative and, more rarely, qualitative abnormalities of myelopoiesis. The authors report the clinical data
Autor:
J R, Delpero, J A, Gastaut, Y P, Letreut, A, Caamano, N, Mathieu-Tubiana, D, Maraninchi, C, Simon-Lejeune, B, Mascret, A P, Blanc, G, Sebahoun
Publikováno v:
Cancer. 59(2)
Between January 1, 1980, and July 31, 1985, 168 patients were treated at our institution for chronic lymphocytic leukemia (CLL). Splenectomy was performed on 32 (23 men and 9 women). The mean age of these surgical patients was 59.4 years (range, 43-7
Autor:
M F, Berthéas, D, Frappaz, B, Mascret, M, Lafage, D, Maraninchi, Y, Carcassonne, C P, Brizard, F, Freycon, J, Fraisse
Publikováno v:
Pathologie-biologie. 34(7)
Cytogenetic studies using constitutive heterochromatin variations represent one of the best method in documentation of allogeneic bone marrow transplantation (BMT). Sex mismatched transplants are evaluated by gonosomal examination. In sex matched pat
Autor:
D, Maraninchi, J L, Pico, O, Hartmann, J A, Gastaut, D, Kamioner, M, Hayat, B, Mascret, F, Beaujean, G, Sebahoun, G, Novakovitch
Publikováno v:
Cancer treatment reports. 70(4)
Dose-effect relationships of high-dose melphalan were evaluated in 37 patients with measurable relapsed or refractory acute leukemias. Thirteen patients (Group 1) received 70-100 mg/m2 of melphalan without marrow rescue and 24 patients (Group 2) rece
Autor:
G, Michel, D, Maraninchi, H, Perrimond, B, Mascret, A, Orsini, J A, Gastaut, C, Raybaud, D, Blaise, F, Demeocq, G, Sebahoun
Publikováno v:
Archives francaises de pediatrie. 43(10)
Twenty-six children with acute leukemia were treated with allogeneic marrow transplantation from HLA identical siblings after a conditioning regimen with Cyclophosphamide-total body irradiation (19 patients), Melphalan-total body irradiation (6 patie
Autor:
J L, Pico, O, Hartmann, D, Maraninchi, F, Beaujean, E, Benhamou, B, Mascret, G, Novakovitch, R, Ghalie, C, Kalifa, M, Hayat
Publikováno v:
Journal of the National Cancer Institute. 76(6)
Twenty-four poor-risk patients with acute lymphoblastic leukemia received a modified regimen of carmustine, cytarabine, cyclophosphamide, and 6-thioguanine (BACT) followed by autologous bone marrow transplantation (ABMT). Nineteen patients were in se
Autor:
Kalifa C, G. Novakovitch, D. Maraninchi, Jean Lemerle, J. L. Pico, Y. Carcassonne, Ellen Benhamou, B. Mascret, R. Ghalie, Catherine Patte, Hartmann O, M. Hayat, F. Beaujean
Publikováno v:
JNCI: Journal of the National Cancer Institute.
Twenty-four poor-risk patients with acute lymphoblastic leukemia received a modified regimen of carmustine, cytarabine, cyclophosphamide, and 6-thioguanine (BACT) followed by autologous bone marrow transplantation (ABMT). Nineteen patients were in se